|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
7th Anti-Bacterial World Summit | ||||||||||||||||
December 31, 2002 | ||||||||||||||||
Strategic Research Institute, Hyatt Regency Princeton - Princeton, NJ 24-25 March 2003 Why is Big Pharma Getting Out of Anti-Bacterial Research? …And Why is Little Pharma Staying In? Resistance in Fluroquinolones: Mechanisms and Epidemiology Histidine Kinase–Mediated Signal Transduction Systems as Target for Therapeutic Intervention Marine Microbes: The Next Generation of Pharmaceutical Chemists etc... |
||||||||||||||||
Organized by: | Mark Alexay/Jon Liong | |||||||||||||||
Invited Speakers: | Abbott Laboratories Affinnium Arpida AG Cetek Corporation Chiron Corporation Cumbre Enanta Pharmaceuticals Essential Therapeutics Genome Therapeutics Genesoft Pharmaceuticals Johnson & Johnson PRI NewBiotics Nereus Pharmaceuticals Novozymes Biotech Quorex Rib-X Sequella Versicor Wyeth-Ayerst Research Hartford Hospital Massachusetts General Hospital The Scripps Research Institute |
|||||||||||||||
Deadline for Abstracts: | www.srinstitute.com/cs246 | |||||||||||||||
Registration: | www.srinstitute.com/cs246 | |||||||||||||||
E-mail: | jliong@srinstitute.com | |||||||||||||||
Posted by: | Adele Carfi | |||||||||||||||
Host: | 12.3.58.15 | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |